Skip to content

California · Nonprofit

MOLECULAR MEDICINE RESEARCH INSTITUTE

MOLECULAR MEDICINE RESEARCH INSTITUTE (California) receives grants from 3 organizations whose IRS filings report $375,112 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($300,000). 2 of them have funded it in more than one year, and 80% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.

Revenue FY2023
$1.6M
Funders on record
3
Grants received
$375k
Net assets
$423k
2/3 repeat funderspeak grant-dependency 5%
01What it does

What Molecular Medicine Research Institute does

Mission

Scientific & medical research

As stated on its FY2023 Form 990.

Programs

  1. Immunology

    $162,975 spent$277,298 earned by the program
    20% of program spending
  2. Cancer

    $252,614 spent$426,636 earned by the program
    31% of program spending
  3. Inflammation

    $130,381 spent$220,199 earned by the program
    16% of program spending
  4. Bacteriology research, disease detection, metabolic research, energy research, neurological diseases research, other biomedical research

    $268,911 spent$452,111 earned by the program
    33% of program spending

The 4 programs described on its FY2023 Form 990, listed largest first by expense. Program spending in total: $814,881.

02The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20172017 Revenue 100 ($3.9M) Expenses 100 ($3.2M) Net assets -8 ($-164141)2018 Revenue 152 ($5.9M) Expenses 111 ($3.6M) Net assets 100 ($2.1M)2019 Revenue 91 ($3.5M) Expenses 106 ($3.5M) Net assets 104 ($2.2M)2020 Revenue 75 ($2.9M) Expenses 101 ($3.3M) Net assets 86 ($1.8M)2021 Revenue 72 ($2.8M) Expenses 94 ($3.0M) Net assets 75 ($1.6M)2022 Revenue 72 ($2.8M) Expenses 86 ($2.8M) Net assets 75 ($1.6M)2023 Revenue 41 ($1.6M) Expenses 89 ($2.9M) Net assets 20 ($423k)
2017201820192020202120222023
Revenue (41)Expenses (89)Net assets (20)Peer revenue range

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2017 to 2018, from $794k to $3.5M (+339%).

$794k
$3.5M
$3.4M
$3.3M
$3.5M
$3.2M
$3.0M
2017201820192020202120222023
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2017
2018
2019
2020
2021
2022
2023
ContributionsProgram revenueInvestmentOther

Government-grant reliance: 2021 11% · 2022 19% · 2023 12%. Grants only. Government contracts and fees sit inside program revenue.

12% of MOLECULAR MEDICINE RESEARCH INSTITUTE’s revenue is contributions — more earned-revenue than three-quarters of its peers (67% for the typical peer).

This organization
Typical peer · 498 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 4 of the last 7 reported years ran a deficit.

$631k
’17
$2.3M
’18
$79k
’19
−$376k
’20
−$243k
’21
−$673
’22
−$1.3M
’23
0.1
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

Chief executive

Edward P Amento Md

CEO&treasurer

As listed on its FY2023 Form 990.

2017201820192020202120222023
Listed7777775
Joined·+1+0+1+0+0+0
No longer listed·101002
03Who funds it

Who funds it, year by year

2017 → 2023: the base held at 1 funder, grant income fell $150k → $26.

Funder
'17
'18
'20
'21
'22
'23
total
funders
1
1
1
1
2
1

2 of 3 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 80% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

From the IRS filings of MOLECULAR MEDICINE RESEARCH INSTITUTE’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

MOLECULAR MEDICINE RESEARCH INSTITUTE leans on a few funders — its largest provides 80% of grant income and the top three 100%; half comes from just 1 funder.

the vertical line marks half of all grant income — 1 funder to its left

100% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund MOLECULAR MEDICINE RESEARCH INSTITUTE.

80%
largest funder
100%
top three
~1
effective funders

Largest funder’s share by year: 2017 100% · 2018 100% · 2020 100% · 2021 100% · 2022 100% · 2023 100% — broadly stable.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

Where its funders are

80% of MOLECULAR MEDICINE RESEARCH INSTITUTE's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $75k that is directly attributable, 100% of it comes from funders outside California, across 1 state.

VA

Funder states come from each funder’s own filing. $300k arriving through sponsors registered in 2 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Against its field

MOLECULAR MEDICINE RESEARCH INSTITUTE's revenue fell 59% between 2017 and 2023.

Operating margin−84% · bottom quartile
Months of reserve0.1mo · bottom quartile
Revenue growth (annualized)−14% · bottom quartile

this organization peer median middle 50% of peers· 436 science & tech nonprofits $1M–$10M, FY2023

Government funding MOLECULAR MEDICINE RESEARCH INSTITUTE receives

Grants and contracts to this organization from federal (USASpending) and state checkbooks, reconciled to its EIN. $1.2M on record.

Federal$1.2M
grants $1.2Mcontracts $0
19
20
21
22
23
24
25
Top agencies
  • Department of Health and Human Services$1.2M

Federal grants vs contracts are distinguished; state line items keep their reported category. Matched by name + geography (the BMF), so coverage is partial and precision-first.

Organizations like MOLECULAR MEDICINE RESEARCH INSTITUTE

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In California

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

28% of spending goes to programs.

Program 28%Management 72%Fundraising 0%

Governance

4
board members
75%
independent
✓Conflict-of-interest policy✓Whistleblower policy✓Document retention✓Board reviewed the 990–Audited financials

Public support

100%

Share of support from the public (Schedule A) — the basis for its public-charity status.

Footprint & structure

Files a return copy in 1 state

CA

Part of a family of 1 related entity

  • 428 Oakmead Holdings LLC · partnership

Screen this organization

A dated, signed PDF of the compliance screen for MOLECULAR MEDICINE RESEARCH INSTITUTE: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds MOLECULAR MEDICINE RESEARCH INSTITUTE?
MOLECULAR MEDICINE RESEARCH INSTITUTE (California) receives grants from 3 organizations whose IRS filings report $375,112 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($300,000). 2 of them have funded it in more than one year, and 80% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
How many funders does MOLECULAR MEDICINE RESEARCH INSTITUTE have?
IRS filings report 3 organizations giving $375,112 in grants to MOLECULAR MEDICINE RESEARCH INSTITUTE, 2 of which have funded it in more than one year.
Who is the largest funder of MOLECULAR MEDICINE RESEARCH INSTITUTE?
FIDELITY INVESTMENTS CHARITABLE GIFT FUND is the largest funder on record, with $300,000 in grants. The full list of funders is on this page.
How can an organization like MOLECULAR MEDICINE RESEARCH INSTITUTE find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in California. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

Play a game about who funds Molecular Medicine Research Institute →

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2023 (financials across 2017–2023), and the filings of 3 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing